Korian
Korian (KORI.PA) Stock Competitors & Peer Comparison
See (KORI.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KORI.PA | €7.36 | -3.79% | 778.6M | 29.44 | €0.25 | N/A |
| CLARI.PA | €4.43 | -2.77% | 1.6B | -110.65 | -€0.04 | N/A |
| ORP.PA | €8.39 | +3.94% | 1.3B | 0.06 | €129.13 | N/A |
| GDS.PA | €10.45 | -0.48% | 1.2B | -14.51 | -€0.72 | N/A |
| LNA.PA | €28.30 | -0.70% | 289.4M | 13.29 | €2.13 | +4.59% |
| PNSB.BR | €0.40 | N/A | 245K | N/A | N/A | N/A |
| MLSBT.PA | €5.30 | -2.75% | 0 | -17.10 | -€0.31 | N/A |
| ESP.AS | €0.01 | +0.00% | 0 | -0.01 | -€0.92 | N/A |
Stock Comparison
KORI.PA vs CLARI.PA Comparison August 2025
KORI.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KORI.PA stands at 778.6M. In comparison, CLARI.PA has a market cap of 1.6B. Regarding current trading prices, KORI.PA is priced at €7.36, while CLARI.PA trades at €4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KORI.PA currently has a P/E ratio of 29.44, whereas CLARI.PA's P/E ratio is -110.65. In terms of profitability, KORI.PA's ROE is +0.01%, compared to CLARI.PA's ROE of -0.00%. Regarding short-term risk, KORI.PA is more volatile compared to CLARI.PA. This indicates potentially higher risk in terms of short-term price fluctuations for KORI.PA.Check CLARI.PA's competition here